Related Experiment Video
Updated: May 2, 2026
A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice
Published on: September 26, 2011
New methods to control neuroblastoma growth
1Department of Biochemistry and Molecular Biology; Massey Cancer Center; Virginia Commonwealth University; Richmond, VA USA.
Abstract:
Downstream of growth factor receptors, signaling by the phosphoinositide 3 kinase (PI3K) pathway is known to play an important role in the growth and survival of many tumor types. The PI3K pathway simplistically comprises PI3K itself, followed by PDK-1, then AKT and finally glycogen synthase kinase 3 (GSK3). PI3K/AKT signaling promotes increased GSK3 phosphorylation, that is associated with reduced GSK3 activity. There are two isoforms of GSK3, GSK3α and GSK3β, which have a high degree of sequence homology. GSK3 plays a role not only in the regulation of glycogen synthase activity but in the expression of multiple other proteins that play a role in cancer biology, including cyclins and anti-apoptotic proteins.
Insights
The phosphoinositide 3 kinase (PI3K) pathway is crucial for tumor growth and survival. PI3K/AKT signaling impacts glycogen synthase kinase 3 (GSK3) activity, affecting proteins vital for cancer biology.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The phosphoinositide 3 kinase (PI3K) pathway is a critical signaling cascade downstream of growth factor receptors.
- This pathway plays a significant role in the proliferation and survival of various cancer types.
- Key components include PI3K, PDK-1, AKT, and glycogen synthase kinase 3 (GSK3).
Purpose of the Study:
- To elucidate the role of the PI3K pathway in cancer.
- To understand the regulatory relationship between PI3K/AKT signaling and GSK3 activity.
- To highlight the implications of GSK3 in cancer biology.
Main Methods:
- The study reviews the molecular mechanisms of the PI3K pathway.
- It examines the signaling cascade from PI3K to GSK3.
- Literature analysis on the function of GSK3 isoforms (GSK3α and GSK3β) in cancer.
Main Results:
- PI3K/AKT signaling leads to increased phosphorylation of GSK3, consequently reducing its activity.
- GSK3 isoforms, GSK3α and GSK3β, exhibit high sequence homology.
- GSK3 influences glycogen synthase activity and the expression of proteins involved in cancer, such as cyclins and anti-apoptotic proteins.
Conclusions:
- The PI3K/AKT/GSK3 axis is a key regulator in cancer cell growth and survival.
- Dysregulation of GSK3 activity through this pathway has significant implications for tumor progression.
- Targeting components of this pathway may offer therapeutic strategies for cancer treatment.
